Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 223

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19

Open access
Mirabelli, Carmen, Wotring, Jesse W., Zhang, Charles J., McCarty, Sean M., Fursmidt, Reid, Pretto, Carla D., Qiao, Yuanyuan, Zhang, Yuping, Frum, Tristan, Kadambi, Namrata S., Amin, Anya T., O’Meara, Teresa R., Spence, Jason R., Huang, Jessie, Alysandratos, Konstantinos D., Kotton, Darrell N., Handelman, Samuel K., Wobus, Christiane E., Weatherwax, Kevin J., Mashour, George A., O’Meara, Matthew J., Chinnaiyan, Arul M., Sexton, Jonathan Z. · 2021 · Proceedings of the National Academy of Sciences

Published version of a preprint

Abstract

Significance: Since its emergence in China in December 2019, SARS-CoV-2 has caused a global pandemic. Repurposing of FDA-approved drugs is a promising strategy for identifying rapidly deployable treatments for COVID-19. Herein, we developed a pipeline for quantitative, high-throughput, image-based screening of SARS-CoV-2 infection in human cells that led to the identification of several FDA-approved drugs and clinical candidates with in vitro antiviral activity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.2105815118

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 47

  1. 10.1053/j.gastro.2020.02.055 · DOI · Paper page
  2. 10.1136/gutjnl-2020-321013 · DOI · Paper page
  3. 10.1111/jce.14479 · DOI · Paper page
  4. 10.1056/NEJMoa1910993 · DOI · Paper page
  5. 10.1016/j.ddstr.2011.10.002 · DOI · Paper page
  6. 10.1038/s41586-020-2577-1 · DOI · Paper page
  7. M. Dittmar . Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2. Cell Rep . 35 108959 (2021). · DOI · Paper page
  8. 10.1016/j.phrs.2020.104960 · DOI
  9. 10.1371/journal.pbio.2005970 · DOI · Paper page
  10. 10.1016/j.cell.2020.06.034 · DOI · Paper page
  11. 10.1073/pnas.2008176117 · DOI · Paper page
  12. 10.12659/MSM.899591 · DOI
  13. K. Heiser . Identification of potential treatments for COVID-19 through artificial intelligence-enabled phenomic analysis of human cells infected with SARS-CoV-2. bioRxiv [Preprint] (2020). https://doi.org/10.1101/2020.04.21.054387 (Accessed 3 June 2021). · DOI
  14. 10.1016/j.stem.2019.12.009 · DOI
  15. 10.1183/13993003.00607-2020 · DOI · Paper page
  16. 10.3389/fimmu.2020.01221 · DOI · Paper page
  17. 10.1371/journal.pone.0023710 · DOI · Paper page
  18. 10.1016/S0006-291X(86)80253-4 · DOI · Paper page
  19. 10.1038/aps.2013.200 · DOI · Paper page
  20. 10.1016/j.cell.2020.04.026 · DOI · Paper page
  21. 10.1074/jbc.M414139200 · DOI · Paper page
  22. 10.1159/000450788 · DOI
  23. 10.3390/cells8080919 · DOI
  24. 10.1016/j.patter.2020.100090 · DOI
  25. M. M. Ghahremanpour . Identification of 14 known drugs as inhibitors of the main protease of SARS-CoV-2. ACS Med. Chem. Lett. 11 2526–2533 (2020). · DOI · Paper page
  26. 10.1016/j.virusres.2017.11.024 · DOI
  27. 10.1038/sj.leu.2404750 · DOI · Paper page
  28. 10.1016/j.jmii.2020.03.005 · DOI · Paper page
  29. 10.1128/JVI.01705-06 · doi:10.1128/jvi.01705-06
  30. 10.1053/j.gastro.2020.02.054 · DOI · Paper page
  31. S. Yuan . Clofazimine broadly inhibits coronaviruses including SARS-CoV-2. Nature 593 418–423 (2021). · DOI · Paper page
  32. 10.1186/1471-2172-6-2 · DOI · Paper page
  33. 10.14309/ajg.0000000000000664 · DOI · Paper page
  34. 10.1139/bcb-2020-0035 · DOI
  35. 10.1007/s10534-014-9742-7 · DOI
  36. P. Conti ., Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by coronavirus-19 (COVI-19 or SARS-CoV-2): Anti-inflammatory strategies. J. Biol. Regul. Homeost. Agents 34, 327–331 (2020).
  37. 10.1002/jmv.25900 · DOI · Paper page
  38. 10.1016/S0140-6736(20)31042-4 · DOI · Paper page
  39. 10.1038/s41596-019-0220-0 · DOI · Paper page
  40. 10.1145/1656274.1656280 · DOI · Paper page
  41. J.-L. R. Stevens, P. Rudiger, J. A. Bednar, “HoloViews: Building complex visualizations easily for reproducible science” in Proceedings of the 14th Python in Science Conference (SciPy, 2015), pp. 61–69.
  42. 10.1161/01.CIR.67.6.1347 · DOI · Paper page
  43. P. C. Feng, C. C. Fenselau, R. R. Jacobson, Metabolism of clofazimine in leprosy patients. Drug Metab. Dispos. 9, 521–524 (1981).
  44. 10.1002/j.1552-4604.1986.tb02962.x · DOI
  45. 10.1371/journal.pone.0136369 · doi:10.1371/journal.pone.0136369
  46. 10.1046/j.0306-5251.2001.01391.x · doi:10.1046/j.0306-5251.2001.01391.x
  47. C. Mirabelli . Effect of lactoferrin treatment on iAEC2. Gene Expression Omnibus. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE171390. Deposited 2 April 2021.

Cited by

See all 223

Metadata

Authors
Mirabelli, C., Wotring, J. W., Zhang, C. J., McCarty, S. M., Fursmidt, R., Pretto, C. D., Qiao, Y., Zhang, Y., Frum, T., Kadambi, N. S., Amin, A. T., O’Meara, T. R., Spence, J. R., Huang, J., Alysandratos, K. D., Kotton, D. N., Handelman, S. K., Wobus, C. E., Weatherwax, K. J., Mashour, G. A., O’Meara, M. J., Chinnaiyan, A. M., & Sexton, J. Z.
Venue
Proceedings of the National Academy of Sciences
Published
2021-08-19
Volume
118
Issue
36
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W3195203505
Cited by
223
References
11
FWCI
13.77
Type
journal article
Language
en
Open access
hybrid
Funders
  • University of Michigan Institute for Clinical and Health Research (NCATS - UL1TR002240, UL1TR002240)
  • HHS | NIH | National Cancer Institute (P30CA046592 COVID-19 Administrative Supplement, R35CA231996)
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01DK120623)
  • Pharmacological Sciences Training Grant (T32)
  • Marie-Slodowska Curie Fellowship (GA - 841247)
  • Pulmonary Fibrosis Foundation (Junior Investigator Award)
  • HHS | NIH | National Heart, Lung, and Blood Institute (R01HL119215)
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (U19AI116482)
  • Chan Zuckerberg Initiative (CZF2019-002440)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19. https://app.cochat.ai/papers/10.1073/pnas.2105815118
The paper
Mirabelli, C., Wotring, J. W., Zhang, C. J., McCarty, S. M., Fursmidt, R., Pretto, C. D., Qiao, Y., Zhang, Y., Frum, T., Kadambi, N. S., Amin, A. T., O’Meara, T. R., Spence, J. R., Huang, J., Alysandratos, K. D., Kotton, D. N., Handelman, S. K., Wobus, C. E., Weatherwax, K. J., . . . Sexton, J. Z. (2021). Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2105815118

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.